Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO
02 juil. 2024 08h30 HE
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, Inc. announced today that Michel Dahan has joined the company as President and Chief Executive Officer.
Vaxcyte Appoints John Furey to Board of Directors
02 juil. 2024 08h30 HE
|
Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
Endeavor Venture Funds and Keiretsu Forum Forge Strategic Alliance to Enhance Early-Stage Investment Opportunities
02 juil. 2024 07h05 HE
|
Keiretsu Forum Mid-Atlantic
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Endeavor Venture Funds and Keiretsu Forum Mid-Atlantic, South-East, and Texas announce a key strategic alliance aimed at increasing investment...
Penicillin Drug Market Is Expected To Reach a Revenue Of USD 13.4 Bn By 2033, at 3.8% CAGR: Dimension Market Research
01 juil. 2024 11h48 HE
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Penicillin Drug Market is predicted to reach a size of over USD 9.6 billion by 2024, and then it is expected to grow to more than USD...
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
28 juin 2024 07h00 HE
|
23andMe, Inc.
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in...
Alumis Announces Pricing of Initial Public Offering
27 juin 2024 23h57 HE
|
Alumis Inc.
Alumis, a clinical-stage biopharmaceutical company developing oral therapies for immune mediated diseases, announces pricing of initial public offering
Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management
27 juin 2024 09h00 HE
|
Blue Mountain
Blue Mountain and Zifo announce a partnership to enhance efficiency and innovation in the life sciences sector, offering advanced solutions for GMP.
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
27 juin 2024 08h05 HE
|
Tourmaline Bio, Inc.
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
27 juin 2024 08h00 HE
|
Quoin Pharmaceuticals, Inc.
Clinical site to be Opened in Saudi Arabia Site Currently Treating Netherton Patients Who Are Eligible for Recruitment into Quoin Studies Experienced Local Clinical Research Organization Has...
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
26 juin 2024 17h30 HE
|
Regeneron Pharmaceuticals, Inc.
Majority of patients in this age group with eosinophilic esophagitis (EoE) receiving Dupixent achieved histologic remission, with improvements sustained up to one year Dupixent is the first and only...